- Price
- $86.20
- Day
- -0.55%
- Mkt Cap
- $110.34B
- 52W Range
- $73.31 – $106.33
- Volume
- 4.42M
- Beta
- 0.58
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
These stocks pay between 3.4% and 6.1% in dividends.
Read full article
The latest trading day saw Medtronic (MDT) settling at $86.68, representing a +1.51% change from its previous close.
Read full article
Avidity Partners Management LP lessened its holdings in Medtronic PLC (NYSE: MDT) by 7.1% in the undefined quarter, according to its most recent filing with the SEC. The firm owned 100,000 shares of the medical technology company's stock after selling 7,600 shares during the period. Medtronic comprises 1.7% of Avidity Partners Management LP's
Read full article
Medtronic (MDT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Read full article
Medtronic could finally be on the cusp of a long-awaited turnaround.
Read full article
Medtronic (MDT) closed at $84.22 in the latest trading session, marking a +1.21% move from the prior day.
Read full article
Orchestra BioMed is approaching pivotal trial readouts for AVIM Therapy and Virtue SAB, both with strong success potential. OBIO operates as an innovation and clinical development platform for medical devices, relying on Medtronic and Terumo for commercialization. Medtronic and Terumo have invested a combined $146 million, with OBIO's $220 million valuation reflecting a modest premium to strategic funding and with significant potential upside as catalysts approach.
Read full article
Andra AP fonden lowered its stake in Medtronic PLC (NYSE: MDT) by 3.9% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 253,329 shares of the medical technology company's stock after selling 10,400 shares during the quarter. Andra AP fonden's holdings in
Read full article
Advanced compute power, built on NVIDIA infrastructure, enables real-time decision support during the procedure FDA-cleared Instrument Exit Point (IEP), the first real-time AI application for robotic procedures from Medtronic, advances a precise, predictable, and personalized future for surgery GALWAY, Ireland, July 21, 2026 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, is presenting an early look at its next-generation compute platform for the operating room. Touch Surgery™ Aide — an AI-native surgical computing platform that powers the Touch Surgery™ ecosystem — enables real-time artificial intelligence during procedures.
Read full article
Medtronic (MDT) reached $82.35 at the closing of the latest trading day, reflecting a -1.13% change compared to its last close.
Read full article
Decker Wealth Management LLC bought a new position in shares of Medtronic PLC (NYSE: MDT) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 58,614 shares of the medical technology company's stock, valued at approximately $5,079,000. Other
Read full article
GALWAY, Ireland, July 20, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results on Tuesday, September 1, 2026, for its first quarter of fiscal year 2027, which ends on Friday, July 31, 2026. A news release containing summary financial information will be issued at 5:45 a.m.
Read full article